Scholar Rock Shares Design of Phase 3 Trial Testing of Apitegromab & Staying Organized With SMA

SMA News Today’s multimedia associate, Price Wooldridge, discusses Scholar Rock's global apitegromab trial, likely to open next year, will test its muscle-directed therapy in type 2 and 3 patients ages 2–21.Also, Alyssa Silva’s recent column is timely as it is a popular time of the year for organization. In, “Staying Organized Helps Me Simplify Life With SMA,” she talks about ways she stays organized so when life becomes overwhelming, she doesn’t have to worry about small things like where her cell phone charger is. Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/